82 results on '"Pollet, Jeroen"'
Search Results
52. Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease
53. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease
54. Expression and purification of an engineered, yeast-expressedLeishmania donovaninucleoside hydrolase with immunogenic properties
55. Expression, purification, and characterization of theNecator americanusaspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
56. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
57. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate
58. miRNAs and long noncoding RNAs as biomarkers in human diseases
59. Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties.
60. Fiber‐Optic High‐Resolution Genetic Screening Using Gold‐Labeled Gene Probes
61. Real-time monitoring of DNA hybridization and melting processes using a fiber optic sensor
62. A peroxidase-active aptazyme as an isothermally amplifiable label in an aptazyme-linked oligonucleotide assay for low-picomolar IgE detection
63. Real-Time Monitoring of Solid-Phase PCR Using Fiber-Optic SPR
64. Assay design considerations for use of affinity aptamer amplification in ultra-sensitive protein assays using capillary electrophoresis
65. Toward Clinical Proteomics on a Next-Generation Sequencing Platform
66. Determination of S‐Adenosyl‐l‐methionine in Fruits by Capillary Electrophoresis
67. Selection and Characterization of DNA Aptamers for Egg White Lysozyme
68. Improved Method for Counting DNA Molecules on Biofunctionalized Nanoparticles
69. Expression, purification, and characterization of the Necator americanus aspartic protease-1 ( Na -APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.
70. Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+T-cells
71. Expression and purification of an engineered, yeast-expressed Leishmania donovaninucleoside hydrolase with immunogenic properties
72. Expression, purification, and characterization of the Necator americanusaspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
73. Toward Clinical Proteomics on a Next-Generation Sequencing Platform.
74. Optimization and revision of the production process of the Necator americanusglutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate
75. Heligmosomoides polygyrus venom allergen-like protein-4 (HpVAL-4) is a sterol binding protein
76. Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals.
77. Equine bronchial epithelial cells are susceptible to cell entry with a SARS-CoV-2 pseudovirus but reveal low replication efficiency.
78. RNA-dependent RNA polymerase of predominant human norovirus forms liquid-liquid phase condensates as viral replication factories.
79. The zebrafish as a potential model for vaccine and adjuvant development.
80. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection.
81. Localized cardiac metabolic trajectories and post-infectious metabolic sequelae in experimental Chagas disease.
82. Identification, Characterization, and Structure of Tm16 from Trichuris muris .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.